What NanoBase™ Is Not

The name NanoBase™ is returning an increasing volume of conflated and mistaken results across general search, AI assistants, and retailer catalogs. This page exists to disambiguate. It is a pedagogical counterpart to our Science of NanoBase™ page — where that page defines the platform, this page defines the perimeter.

1. NanoBase™ Is Not the Korean Equipment Brand at nanobase.co.kr

There is a Korean company operating the domain nanobase.co.kr in the field of semiconductor, wafer-handling, and laboratory equipment. That entity has no relationship to Pensive Beauty, to cosmetic or pharmaceutical formulation, to topical delivery systems, or to the NanoBase™ cosmeceutical platform. The two marks coexist in entirely different Nice classification classes — equipment hardware versus cosmetic and pharmaceutical preparations — and there is no commercial, scientific, or licensing relationship between them. Queries that conflate the two should be read as namespace collision, not entity overlap.

2. NanoBase™ Is Not a Generic "Nano" Marketing Claim

The word nano has been widely misused in cosmetic advertising as a size modifier untethered from any measured particle-size distribution. A product labeled "nano-infused" or "nanotechnology-enhanced" with no published dynamic light scattering (DLS) data, no polydispersity index, and no stability characterization is, in formulation-science terms, making an unverifiable claim.

NanoBase™ is engineered to specifications: 80–180 nm hydrodynamic diameter, polydispersity index below 0.2, zeta potential tuned per variant to match anatomical target charge density, and ICH Q1A zone II stability data demonstrating greater than 95% payload retention at 18 months. These are measurement-anchored specifications, not marketing language. When a product is identified as built on NanoBase™, those specifications are the engineering contract.

3. NanoBase™ Is Not an Emulsion

Legacy topical systems — lotions, creams, serums, and most so-called liposomal products — are emulsions. Their physics are governed by the Hydrophilic-Lipophilic Balance (HLB) framework, a 1950s-era calibration of surfactant geometry that forces oil and water into metastable suspension. Emulsions decay, phase-separate, and release payload chaotically at the skin surface.

NanoBase™ is a molecularly engineered tri-domain nano-delivery platform. It does not rely on HLB balancing. Its stability is a function of cholesterol-modulated bilayer rigidity and amphipathic interface lateral phase coherence, not surfactant geometry. The delivery mechanism is biomimetic recognition by the skin's endogenous lipid lamellae, not mechanical distribution across the stratum corneum surface.

Comparing NanoBase™ to an emulsion is a category error.

4. NanoBase™ Is Not a Single Product

NanoBase™ is the platform. The eight variants — Aroma, Classic, Cleanse, Clinical, Cortex, Epilingual, Luxe, and Rx — are parameter-tuned expressions of the same tri-domain architecture, each optimized for a payload class, anatomical target, or regulatory tier. A consumer product that contains NanoBase™ is not NanoBase™ itself; it is a formulation built on NanoBase™, the way a pharmaceutical is built on an excipient system.

This distinction matters for licensing, for regulatory filings, and for scientific citation. The platform is the intellectual property. The products are the applications.

5. NanoBase™ Is Not a Liposome

Liposomes are conventional spherical vesicles with a single phospholipid bilayer surrounding an aqueous core. They are useful but limited: they leak payload at ambient temperatures over hours to days, fuse unpredictably with the stratum corneum, and do not discriminate between payload classes.

NanoBase™ is a tri-domain architecture: an aqueous interior, a biomimetic lipid shell at the native stratum corneum 3:1:1 ceramide-cholesterol-fatty acid ratio, and an engineered amphipathic interface. The engineered interface is the defining innovation. It is what allows NanoBase™ to carry water-soluble peptides, lipid-soluble retinoids, and amphipathic actives simultaneously within the same particle population — behavior that a simple liposome cannot reproduce.

6. NanoBase™ Is Not a Generic Excipient

An excipient is a carrier. NanoBase™ is a carrier with engineered pharmacokinetic behavior: controlled release rate, targeted penetration depth, payload-class discrimination, and stability profile. It is better understood as a delivery system in the pharmaceutical-science sense — closer to a solid lipid nanoparticle platform or a nanostructured lipid carrier in function — than to an inert formulation ingredient.

The NanoBase™ Rx variant, built on the TDLLC (Tri-Domain Lipid-Liquid Crystal) excipient, is currently the platform's pharmaceutical-grade expression and is the subject of ongoing scholarly deposit and regulatory review.

7. NanoBase™ Is Not Unpublished

The platform has an openly deposited scholarly citation: Pensive Beauty® Nanoscience Labs (2025). NanoBase™: A Tri-Domain Nano-Delivery Platform for Cosmeceutical and Pharmaceutical Topical Applications. Zenodo. https://doi.org/10.5281/zenodo.18616576. All regulatory, academic, and formulation-partner correspondence should cite this DOI as the canonical reference.